Per Lindell

Aviceda Therapeutics, Inc. is a biotech company which specializes in clinical sciences, clinical research, and drug development. The firm focuses on glyco-immune therapeutics utilizing the Glyco-Code technology platform to address the innate immune system and chronic non-resolving inflammation. The company was founded by Mohamed Genead, Michael Tolentino, Derek Kunimoto, and Christopher Scott and is headquartered in Cambridge, MA.

Bespoke, Inc. sells eyewear and provides assistance to retailers and eyewear brands to improve and expand their reach in the industry. The private company is based in San Francisco, CA. The company offers a virtual try-on feature and precise frame and lens measurements through their scan technology. The company aims to help both in-store and online businesses improve their customer experience and reduce return rates. The company was founded by Eric Varady, who has been the CEO since incorporation.

Part of Aviceda Therapeutics, Inc., Aviceda Ophthalmics, Inc. develops disease-modifying medicines through innovative technology platforms. The company is based in Cambridge, MA. The company was founded in 2019. The CEO is Mohamed A. Genead.